Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of Isoform-Selective Akt3 Degraders Overcoming Osimertinib-Induced Resistance in Non-Small Cell Lung Cancer Cells
Fang Xu, Xin Zhang, Zhipeng Chen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 20, pp. 14032-14048
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation
Shaowen Xie, Feiyan Zhan, Jingjie Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 13
Open Access | Times Cited: 48
Small-Molecule Hydrophobic Tagging: A Promising Strategy of Druglike Technology for Targeted Protein Degradation
Shaowen Xie, Jingjie Zhu, Junda Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 10917-10933
Closed Access | Times Cited: 40
Hydrophobic tag tethering degrader as a promising paradigm of protein degradation: Past, present and future perspectives
Si Ha, Jiacheng Zhu, Hua Xiang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 8, pp. 109192-109192
Closed Access | Times Cited: 18
Targeting EGFR degradation by autophagosome degraders
ZhongFeng Zhu, Jiaying Li, Shujun Shen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 270, pp. 116345-116345
Closed Access | Times Cited: 8
Selectivity Studies and Free Energy Calculations of AKT Inhibitors
Haizhen A. Zhong, David T. Goodwin
Molecules (2024) Vol. 29, Iss. 6, pp. 1233-1233
Open Access | Times Cited: 7
Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 6
Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders
Xiaomei Li, Mengdie Hu, Yanping Zhang, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107115-107115
Closed Access | Times Cited: 4
Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways
Xiaoyu Ma, Xueyun Wang, Feifei Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 11, pp. 8791-8816
Closed Access | Times Cited: 4
Discovery of Potent and Selective c-Met Degraders for Hepatocellular Carcinoma Treatment
Wenjian Min, Huanaoyu Yang, Dawei Wang, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 4
Anticancer and antibacterial Activeness of fused Pyrimidines: Newfangled Updates
Ayushi Bhatnagar, Gangotri Pemawat
Bioorganic Chemistry (2024) Vol. 153, pp. 107780-107780
Closed Access | Times Cited: 4
Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 4745-4753
Open Access
Comprehensive analysis of the potential mechanism of gansui in blocking non-small cell lung cancer progression
Xiaoxu Yang, Wenlan Li
Pharmaceutical Biology (2025) Vol. 63, Iss. 1, pp. 170-187
Open Access
Discovery of Novel SHP2 ATTEC Degraders against Pancreatic Ductal Adenocarcinoma Harboring KRAS(G12D) Mutations
Yue Zhong, Yan Lü, Jiahui Li, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Proteolysis targeting chimera, molecular glue degrader and hydrophobic tag tethering degrader for targeted protein degradation: Mechanisms, strategies and application
Yutian Pan, Yuanjiang Wang, Shaohua Gou
Bioorganic Chemistry (2025), pp. 108491-108491
Closed Access
Identification of key extracellular proteins as the potential biomarkers in thyroid eye disease
Shasha He, Han Nie, Xiangbao Yin, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0322415-e0322415
Open Access
Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer
Yuchen Yang, Canjun Zhao, Zhao-Feng Jin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
A rapid and accurate method for evaluating the degradation of pan-Akt in cells by PROTACs using NanoLuc luciferase
Xiaojun Ji, Lei Miao, Yebin Wu, et al.
Biology Methods and Protocols (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Current scenario of fused pyrimidines with in vivo anticancer therapeutic potential
Zhi Xu, Li Wang, Hongyan Hu
Archiv der Pharmazie (2024)
Closed Access | Times Cited: 1
Design, synthesis and bioevaluation of dual EGFR-PI3Kα inhibitors for potential treatment of NSCLC
Tingliang Wang, Yujie Wang, Jiangrong Lu, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107714-107714
Closed Access | Times Cited: 1
Research on enzymatic co-assembly nanomedicine in oral squamous cell carcinoma
Zhijun Xue, Yaxuan Guo, Yuanzhu Zhou, et al.
Precision medicine and engineering. (2024) Vol. 1, Iss. 2, pp. 100008-100008
Open Access | Times Cited: 1
Discovery of HyT‐Based Degraders of CDK9‐Cyclin T1 Complex
Rongkun Lin, Jie Yang, Ting Liu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 8
Open Access | Times Cited: 3
An updated patent review of AKT inhibitors (2020 – present)
Linjie Li, Guo Yu, Yang Lu, et al.
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 9, pp. 549-564
Closed Access | Times Cited: 2
Discovery of Norbornene as a Novel Hydrophobic Tag Applied in Protein Degradation
Shaowen Xie, Feiyan Zhan, Jingjie Zhu, et al.
Angewandte Chemie (2023) Vol. 135, Iss. 13
Open Access | Times Cited: 1
Down-regulation of AKT proteins slows the growth of mutant-KRAS pancreatic tumors
Chuankai Chen, Yaping Jiang, Inchul You, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Down-Regulation of AKT Proteins Slows the Growth of Mutant-KRAS Pancreatic Tumors
Chuankai Chen, Yaping Jiang, Inchul You, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1061-1061
Open Access
Page 1 - Next Page

Scroll to top